CYT-015-IL17Qb

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCYT-015-IL17Qb
Drug Alias NameImmunodrug vaccines (Cytos)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInterleukin-17 modulators
TargetsInterleukin-17
Therapy Area/IndicationsMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosciences
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A